Aspect Ventures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Cambridge, MA biotechnology company developing injectable synthetic biomarkers for noninvasive disease staging and treatment monitoring.
BiotechCambridge, US
Gabriel Kwong(Executive Officer)inSangeeta BhatiainRoopom Banerjee(Executive Officer)in
BoardAmy Schulman(Director)Stan Lapidus(Director)in
Board seatTheresia Gouw· per SEC Form D · $46.7M raise · filed Jul 2021
Co-investorsGreatPoint VenturesAcrew CapitalARCH Venture PartnersCatalio Capital ManagementCRV (Charles River Ventures)Dns Capital+7 more
Eden is a platform for creating autonomous generative AI agents ("spirits") that produce creative content collaboratively with people and with each other.
AI & Machine LearningCreator EconomyMedia & Entertainment
Co-investorsGenerative VenturesCompany VenturesFlexcap VenturesInsight PartnersLiquid VenturesMax Ventures+2 more
Informed provides AI-powered employment and income verification solutions for lenders, using document intelligence and historical lending data to automate applicant verification, reduce fraud, and accelerate loan approvals.
AI & Machine LearningEnterprise SoftwareFintechTiburon, US
Justin Wickett(Executive Officer, Director)inJatin Agrawal(Founder)inJames Ramsey(Director)
BoardMagdalena Yesil(Director)Steve Krausz(Director)inJeremy Solomon(Director)
Co-investorsAlly VenturesNycaNyca PartnersOwl CapitalThe Perkins FundUS Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
















